[artículo] 
inThe American Journal of Psychiatry > Año 2025 - Vol. 182 - No.1 (Enero) . - pp. 126-132

Título :	Compass psychological support model for comp360 psilocybin treatment of serious mental health conditions
Tipo de documento:	texto impreso
Autores:	Namik Kirlić, Autor ; Molly Lennard Jones, Autor ; Merve Atli, Autor
Fecha de publicación:	2025
Artículo en la página:	pp. 126-132
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Estudios clínicos de medicamentos, Trastornos depresivos, Combinación de fármacos y psicoterapia, Trastorno depresivo mayor.
Resumen:	The psychedelic experience can be challenging. There is a need for a structured framework for providing psychological support to individuals with mental health conditions receiving investigational psilocybin treatment. The primary benefit of such a framework is to support a safe and meaningful psilocybin experience. It also enables future research on the facets of psychological support and/or psychotherapy that most optimally complement psilocybin treatment.
Link:	./index.php?lvl=notice_display&id=31563

[artículo] Compass psychological support model for comp360 psilocybin treatment of serious mental health conditions [texto impreso] / Namik Kirlić, Autor ; Molly Lennard Jones, Autor ; Merve Atli, Autor . - 2025 . - pp. 126-132.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in The American Journal of Psychiatry > Año 2025 - Vol. 182 - No.1 (Enero) . - pp. 126-132

Palabras clave:	Estudios clínicos de medicamentos, Trastornos depresivos, Combinación de fármacos y psicoterapia, Trastorno depresivo mayor.
Resumen:	The psychedelic experience can be challenging. There is a need for a structured framework for providing psychological support to individuals with mental health conditions receiving investigational psilocybin treatment. The primary benefit of such a framework is to support a safe and meaningful psilocybin experience. It also enables future research on the facets of psychological support and/or psychotherapy that most optimally complement psilocybin treatment.
Link:	./index.php?lvl=notice_display&id=31563